Related references
Note: Only part of the references are listed.Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018
Inmaculada Hernandez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Decreasing Medicare Spending on Prescription Drugs
Robert Steinbrook
JAMA INTERNAL MEDICINE (2020)
Drug Prices, Rebates, and Discounts
Benjamin N. Rome et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
America's Health Care System is Broken: What Went Wrong and How We Can Fix It. Part 4: The Pharmaceutical Industry
Edward P. Hoffer
AMERICAN JOURNAL OF MEDICINE (2019)
Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017
Thomas J. Hwang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Competition and price among brand-name drugs in the same class: A systematic review of the evidence
Ameet Sarpatwari et al.
PLOS MEDICINE (2019)
Price and utilisation differences for statins between four countries
Loc Phuoc Thai et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2018)
Generic Price Competition For Specialty Drugs: Too Little, Too Late?
Ashley L. Cole et al.
HEALTH AFFAIRS (2018)
Health Care Spending in the United States and Other High-Income Countries
Irene Papanicolas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Price comparison of high-cost originator medicines in European countries
Sabine Vogler et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
Prices of Generic Drugs Associated with Numbers of Manufacturers
Chintan V. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Determinants of orphan drugs prices in France: a regression analysis
Daria Korchagina et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Association of Prescription Drug Price Rebates inMedicare Part D With Patient Out-of-Pocket and Federal Spending
Stacie B. Dusetzina et al.
JAMA INTERNAL MEDICINE (2017)
Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countries
Livio Garattini et al.
HEALTH POLICY (2008)
Pharmaceutical regulation in France 1980-2003
V Paris
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2005)
Medication costs, adherence, and health outcomes among Medicare beneficiaries
R Mojtabai et al.
HEALTH AFFAIRS (2003)